Novartis AG (NVS) stock forecast for 2024

The forecast has been updated: June 7, 2023 14:06


Novartis AG stock price online today

Analyst Target Price

110.75

Dividend Date

20.03.2023

Ex Dividend Date

09.03.2023

Last Split Factor

Last Split Date

01.01.1970

Should you buy or sell Novartis AG stock stock today? What is the projected target price level for 2024? How much will it cost in 2024? Novartis AG stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2024.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $110.75 target price for Novartis AG stock stock.

Today 200 Day Moving Average is the support level (88.07 $).

50 Day Moving Average is the support level (98.75 $).




NVS Forecast for 2024

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 103.39 100.62 104.80 3.99 %
Feb 104.22 101.76 106.47 4.42 %
Mar 104.01 103.09 105.30 2.09 %
Apr 104.05 102.88 106.59 3.48 %
May 105.17 102.40 106.90 4.21 %
Jun 104.12 101.54 106.33 4.50 %
Jul 106.16 104.21 109.52 4.85 %
Aug 109.01 107.92 112.23 3.85 %
Sep 110.53 109.21 112.21 2.68 %
Oct 113.27 110.24 114.68 3.87 %
Nov 115.31 112.41 118.17 4.88 %
Dec 119.19 116.52 121.43 4.04 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Novartis AG stock.


Novartis AG overview

Novartis AG Address

LICHTSTRASSE 35, BASEL, CH

Market Capitalization

211 261 522 000 $

EBITDA

18 592 999 000

PE Ratio

30.02

PEG Ratio

5.77

Dividend Per Share

3.461

Dividend Yield

0.036

EPS

3.32

Quarterly Earnings Growth YOY

0.091

Quarterly Revenue Growth YOY

0.031

Trailing PE

30.02

Forward PE

14.53

EV To Revenue

3.968

EV To EBITDA

6.66

52 Week High

105.56

52 Week Low

71.0

50 Day Moving Average

98.75

200 Day Moving Average

88.07

Shares Outstanding

2119610000

Shares Float

Shares Short Prior Month

Short Ratio

Percent Insiders

Percent Institutions

Novartis AG stock forecast for this year


Novartis AG stock forecast for Jan 2024.
Estimated Average Forecasted Novartis AG Price: 103.39. Negative monthly dynamics of the instrument is expected with 3.986% volatility is expected.

Pessimistic forecast: 100.62

Optimistic: 104.80


Novartis AG stock forecast for Feb 2024.
Estimated Average Forecasted Novartis AG Price: 104.22. Positive monthly dynamics of the instrument is expected with 4.425% volatility is expected.

Pessimistic forecast: 101.76

Optimistic: 106.47


Novartis AG stock forecast for Mar 2024.
Estimated Average Forecasted Novartis AG Price: 104.01. Negative monthly dynamics of the instrument is expected with 2.094% volatility is expected.

Pessimistic forecast: 103.09

Optimistic: 105.30


Novartis AG stock forecast for Apr 2024.
Estimated Average Forecasted Novartis AG Price: 104.05. Positive monthly dynamics of the instrument is expected with 3.475% volatility is expected.

Pessimistic forecast: 102.88

Optimistic: 106.59


Novartis AG stock forecast for May 2024.
Estimated Average Forecasted Novartis AG Price: 105.17. Positive monthly dynamics of the instrument is expected with 4.211% volatility is expected.

Pessimistic forecast: 102.40

Optimistic: 106.90


Novartis AG stock forecast for Jun 2024.
Estimated Average Forecasted Novartis AG Price: 104.12. Negative monthly dynamics of the instrument is expected with 4.504% volatility is expected.

Pessimistic forecast: 101.54

Optimistic: 106.33


Novartis AG stock forecast for Jul 2024.
Estimated Average Forecasted Novartis AG Price: 106.16. Positive monthly dynamics of the instrument is expected with 4.847% volatility is expected.

Pessimistic forecast: 104.21

Optimistic: 109.52


Novartis AG stock forecast for Aug 2024.
Estimated Average Forecasted Novartis AG Price: 109.01. Positive monthly dynamics of the instrument is expected with 3.846% volatility is expected.

Pessimistic forecast: 107.92

Optimistic: 112.23


Novartis AG stock forecast for Sep 2024.
Estimated Average Forecasted Novartis AG Price: 110.53. Positive monthly dynamics of the instrument is expected with 2.680% volatility is expected.

Pessimistic forecast: 109.21

Optimistic: 112.21


Novartis AG stock forecast for Oct 2024.
Estimated Average Forecasted Novartis AG Price: 113.27. Positive monthly dynamics of the instrument is expected with 3.873% volatility is expected.

Pessimistic forecast: 110.24

Optimistic: 114.68


Novartis AG stock forecast for Nov 2024.
Estimated Average Forecasted Novartis AG Price: 115.31. Positive monthly dynamics of the instrument is expected with 4.879% volatility is expected.

Pessimistic forecast: 112.41

Optimistic: 118.17


Novartis AG stock forecast for Dec 2024.
Estimated Average Forecasted Novartis AG Price: 119.19. Positive monthly dynamics of the instrument is expected with 4.044% volatility is expected.

Pessimistic forecast: 116.52

Optimistic: 121.43



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 102.62 (06.06.2023) -1.10 %
AbbVie Inc.
ABBV 135.43 (06.06.2023) -1.04 %
Aeterna Zentaris Inc.
AEZS 2.83 (05.06.2023) 2.94 %
Allakos Inc.
ALLK 4.94 (06.06.2023) -3.70 %
Allogene Therapeutics, Inc.
ALLO 5.88 (06.06.2023) 5.57 %
Amgen Inc.
AMGN 221.22 (06.06.2023) -0.30 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 1.64 (06.06.2023) 5.13 %
Aurora Cannabis Inc.
ACB 0.5396 (06.06.2023) 4.92 %
Becton Dickinson and Company
BDX 250.46 (06.06.2023) -1.39 %
Biogen Inc.
BIIB 299.79 (06.06.2023) -0.77 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 22.63 (06.06.2023) 4.53 %
BioNTech SE
BNTX 109.85 (06.06.2023) 1.03 %
bluebird bio, Inc.
BLUE 3.73 (06.06.2023) 0.54 %
Boston Scientific Corp.
BSX 51.4 (05.06.2023) -0.81 %
Bristol-Myers Squibb Company
BMY 65.48 (06.06.2023) -0.76 %
Canopy Growth Corp.
CGC 0.7394 (06.06.2023) -5.57 %
Castle Biosciences, Inc.
CSTL 14.72 (06.06.2023) 26.24 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 3.16 (07.01.2022) -5.67 %
Eli Lilly and Company
LLY 242.27 (04.02.2022) 0.00 %
Emergent BioSolutions Inc.
EBS 7.91 (05.06.2023) -4.00 %
Exelixis, Inc.
EXEL 18.56 (17.06.2022) 5.63 %
G1 Therapeutics, Inc.
GTHX 2.8 (06.06.2023) -0.71 %
Gilead Sciences, Inc.
GILD 77.72 (05.06.2023) -0.22 %
GlaxoSmithKline plc
GSK 34.28 (05.06.2023) 0.50 %
GoodRx Holdings, Inc.
GDRX 5.53 (06.06.2023) 2.60 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 61.71 (06.06.2023) -1.06 %
Inovio Pharmaceuticals, Inc.
INO 0.564 (06.06.2023) -1.91 %
Johnson & Johnson
JNJ 166.11 (13.04.2023) 1.34 %
Medtronic plc.
MDT 83.6 (06.06.2023) -0.16 %
Merck & Co., Inc.
MRK 110.01 (06.06.2023) -2.74 %
Moderna, Inc.
MRNA 126.9 (06.06.2023) -1.55 %
Novartis AG
NVS 99.66 (06.06.2023) 0.29 %
Novavax, Inc.
NVAX 7.23 (06.06.2023) -7.90 %
ObsEva SA
OBSV 0.084 (12.05.2023) 0.00 %
OrganiGram Holdings Inc.
OGI 0.4197 (06.06.2023) 4.93 %
Pfizer Inc.
PFE 38.37 (06.06.2023) -0.72 %
Regeneron Pharmaceuticals, Inc.
REGN 748.14 (06.06.2023) -0.28 %
Sanofi
SNY 51.49 (06.06.2023) 1.30 %
Schrodinger, Inc.
SDGR 38.14 (06.06.2023) 0.00 %
Senseonics Holdings, Inc.
SENS 0.7885 (05.06.2023) 6.55 %
Sorrento Therapeutics, Inc.
SRNE 0.3168 (05.06.2023) 7.35 %
Stryker Corp.
SYK 276.55 (06.06.2023) -0.51 %
Sundial Growers Inc.
SNDL 1.48 (06.06.2023) 2.07 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 7.23 (06.06.2023) 0.28 %
Thermo Fisher Scientific Inc.
TMO 516.26 (06.06.2023) -0.45 %
Tilray, Inc.
TLRY 1.77 (06.06.2023) 4.73 %
UnitedHealth Group, Inc.
UNH 487.57 (06.06.2023) -2.13 %
Veeva Systems Inc.
VEEV 195.98 (06.06.2023) 1.31 %
Zomedica Corp.
ZOM 0.1945 (06.06.2023) -1.27 %
Zynerba Pharmaceuticals, Inc.
ZYNE 0.3326 (06.06.2023) -2.46 %

Warning: include(include/reklama_bottom.php): failed to open stream: No such file or directory in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808 Warning: include(): Failed opening 'include/reklama_bottom.php' for inclusion (include_path='.:') in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808

Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.